多粘菌素B处理空肠弯曲菌外膜囊泡作为鸡黏膜疫苗候选
本研究以非神经节苷脂模拟的空肠弯曲菌株TGH 9011制备外膜囊泡(OMVs),用多粘菌素B(PMB)处理以降低脂寡糖(LOS)内毒素活性。鸡口服壳聚糖包被的PMB处理OMVs后,仍能诱导肠道分泌型IgA和适度细胞免疫,并显著减少盲肠定植。结果表明PMB处理不损害OMVs免疫原性且可减轻LOS内毒素风险。
要点
- PMB处理空肠弯曲菌OMVs可降低LOS驱动的TNFα和IL-1β基因表达。
- 口服壳聚糖包被PMB-OMVs可诱导鸡肠道sIgA和适度细胞免疫。
- 免疫鸡在攻击后盲肠空肠弯曲菌定植较未免疫对照显著减少。
核心结论
- PMB处理不损害空肠弯曲菌天然OMVs的免疫原性,同时有效减轻LOS介导的内毒素风险。
研究设计与样本
- 研究采用非神经节苷脂模拟的空肠弯曲菌株TGH 9011(Penner血清型O:3)制备OMVs,用多粘菌素B处理,并在鸡模型中评估免疫原性与保护效果。
主要发现
- PMB处理空肠弯曲菌LOS可显著降低TNFα和IL-1β基因表达。
- 口服壳聚糖包被的PMB处理OMVs(CS-PMB-OMVs)可诱导功能性肠道分泌型IgA并引起适度细胞免疫。
- 与未免疫对照相比,CS-PMB-OMVs免疫鸡在空肠弯曲菌感染后盲肠定植显著减少。
临床怎么用
- 提示PMB处理的OMVs可作为鸡用黏膜疫苗候选,以减少空肠弯曲菌定植并降低食源性传播风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Campylobacter jejuni (C. jejuni) is the leading cause of bacterial gastroenteritis in humans. Primarily, contaminated poultry meat and meat products account for nearly 80% of human infections. Reducing C. jejuni colonization of the chicken gastrointestinal tract is a key strategy to limit the risk of foodborne transmission to humans. To this end, outer membrane vesicles (OMVs) derived from C. jejuni were shown to have strong immunogenic potential in both avian and mammalian models. However, a major limitation of OMV-based vaccines against C. jejuni is the presence of lipooligosaccharide (LOS) in the outer leaflet of OMVs, which often confers endotoxicity. Additionally, some strains of C. jejuni also express outer-core structures of LOS that mimic human gangliosides, potentially inducing cross-reactive antibody responses. Although avians are less sensitive to endotoxin exposure, a high number of C. jejuni infections in chickens may cause anorexia and impaired nutrient absorption, leading to reduced feed intake and suppressed growth performance in broilers. Here, we explored a simple approach to address the risk of LOS-mediated endotoxic effects of OMVs using a non-ganglioside-mimicking C. jejuni strain (TGH 9011; Penner serotype O: 3). For this, C. jejuni OMVs were treated with an optimal amount of polymyxin B (PMB), a polycationic peptide known to neutralize LOS activity. We confirmed that PMB treatment of C. jejuni LOS substantially reduces the expression of TNFα and IL-1β genes, hallmarks of LOS-driven endotoxic activity. Furthermore, oral administration of chitosan-coated PMB-treated OMVs (CS-PMB-OMVs) retained their ability to induce functional intestinal secretory IgA (sIgA) while eliciting modest cellular immune responses in immunized chickens. Similar to natural OMVs, CS-PMB-OMVs immunized birds exhibited a marked reduction in cecal C. jejuni colonization following C. jejuni infection compared with unvaccinated controls. These findings demonstrate that PMB treatment does not compromise the inherent immunogenicity of natural OMVs, while effectively mitigating the risk of LOS-mediated endotoxicity.
引用
- Khan A, Biswas P, Mondal S, et al. Polymyxin B-treated outer membrane vesicles of Campylobacter jejuni as prospective mucosal vaccine candidates in chickens. Vaccine. 2026. PMID: 41855651. doi:10.1016/j.vaccine.2026.128458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。